Laurus Labs informs about disclosure

10 Feb 2023 Evaluate
Laurus Labs has informed that the United States Food & Drug Administration (USFDA) today completed inspection of our formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh. The inspection was conducted from 6th February, 2023 to 10th February, 2023. It has been issued a Form 483 with two observations. The observations are procedural in nature. The Company will address the observations within stipulated timelines.

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

1014.90 -3.20 (-0.31%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×